下肢慢性静脉病患者中心静脉压升高与阻塞性睡眠呼吸暂停的患病率及预测因素
单中心回顾性描述性研究纳入264例慢性静脉疾病患者,同步行静脉双功超声和右心有限超声心动图评估。22.7%存在中心静脉压升高,26.9%存在阻塞性睡眠呼吸暂停;中心静脉压升高的预测因素包括年龄>64.6岁、糖尿病和右下肢静脉临床严重程度评分≥8.5。
要点
- 慢性静脉疾病患者中中心静脉压升高患病率为22.7%,阻塞性睡眠呼吸暂停为26.9%。
- 年龄>64.6岁、糖尿病、右下肢VCSS≥8.5是中心静脉压升高的预测因素。
- 中心静脉压升高组与正常组的阻塞性睡眠呼吸暂停患病率及体重指数无显著差异。
核心结论
- 与一般人群相比,该慢性静脉疾病队列中中心静脉压升高和阻塞性睡眠呼吸暂停的患病率显著。
- 年龄、糖尿病和右下肢慢性静脉功能不全症状似乎是中心静脉压升高的预测因素。
研究设计与样本
- 单中心、回顾性、描述性研究,纳入转诊至三级医疗中心并诊断为慢性静脉疾病的患者264例。
- 每例患者同时接受静脉双功超声评估静脉反流和右心有限超声心动图评估中心静脉压升高。
- 采用多变量逻辑回归评估中心静脉压升高的患病率和预测因素。
主要发现
- 264例慢性静脉疾病患者中,22.7%存在中心静脉压升高,26.9%存在阻塞性睡眠呼吸暂停。
- 中心静脉压升高组与中心静脉压正常组相比,阻塞性睡眠呼吸暂停患病率和体重指数升高无显著差异。
- 中心静脉压升高的预测因素包括年龄>64.6岁(OR 1.03;95%CI 1.003-1.05;P=.026)。
- 糖尿病(OR 2.19;95%CI 1.05-4.5;P=.035)和右下肢静脉临床严重程度评分≥8.5(OR 1.098;95%CI 1.011-1.193;P=.026)也是中心静脉压升高的预测因素。
- 其他预测因素包括既往肺栓塞病史和肾功能不全。
关键数值与推荐
- 中心静脉压升高定义为右心有限超声心动图评估的右心房压升高。
- 右下肢静脉临床严重程度评分≥8.5与中心静脉压升高相关(OR 1.098;95%CI 1.011-1.193;P=.026)。
- 年龄>64.6岁与中心静脉压升高相关(OR 1.03;95%CI 1.003-1.05;P=.026)。
- 糖尿病与中心静脉压升高相关(OR 2.19;95%CI 1.05-4.5;P=.035)。
临床怎么用
- 对慢性静脉疾病患者,尤其是年龄>64.6岁、合并糖尿病或右下肢症状严重(VCSS≥8.5)者,应考虑评估中心静脉压升高。
- 同步静脉双功超声和右心有限超声心动图可在评估静脉反流的同时筛查中心静脉压升高。
- 对慢性静脉疾病患者应关注阻塞性睡眠呼吸暂停的筛查,其患病率在该队列中达26.9%。
局限性
- 单中心、回顾性、描述性研究设计可能限制因果推断和外推性。
- 需要更大规模、基于人群的患病率研究来确认这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic venous disease (CVD) is a common vascular disorder with manifestations ranging from asymptomatic spider veins to venous ulcers. Elevated right atrial pressure, otherwise called central venous pressure (CVP), can also result in edema and hyperpigmentation similar to chronic venous insufficiency. Obstructive sleep apnea (OSA) is a known risk factor for elevation of CVP. Prevalence rates of elevated CVP or OSA are unknown in patients presenting with a diagnosis of CVD. METHODS: This is a single-center, retrospective, descriptive study of patients referred to our tertiary care center with a diagnosis of CVD. Each patient was evaluated by simultaneous venous duplex ultrasound (to assess venous reflux) and limited echocardiography of the right side of the heart (to assess elevated CVP). We assessed the prevalence and predictors of elevated CVP in this cohort using multivariate logistic regression. RESULTS: A total of 264 patients with CVD were evaluated, and of these, 22.7% had elevated CVP and 26.9% had OSA. There was no significant difference in the prevalence of OSA or elevated body mass index in the group with elevated CVP compared with patients with normal CVP. The predictors of elevated CVP were age >64.6 years (odds ratio [OR], 1.03; 95% confidence interval [CI], 1.003-1.05; P = .026), diabetes mellitus (OR, 2.19; 95% CI, 1.05-4.5; P = .035), and right lower extremity Venous Clinical Severity Score of ≥8.5 (OR, 1.098; 95% CI, 1.011-1.193; P = .026). Other predictors included prior history of pulmonary embolism and renal insufficiency. CONCLUSIONS: Compared with the general population, the prevalence of elevated CVP and OSA is significant in this cohort of patients. Age, diabetes, and right lower extremity chronic venous insufficiency symptoms seem to be predictors of elevated CVP. Larger, population-based prevalence studies are needed to confirm these findings.
引用
- Kolluri R, Bashir R, Matros T, et al. Prevalence and predictors of elevated central venous pressure and obstructive sleep apnea in patients with lower extremity chronic venous disease. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32094062. doi:10.1016/j.jvsv.2019.12.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。